
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition
Kimberley M. Hanssen, Michelle Haber, Jamie I. Fletcher
Drug Resistance Updates (2021) Vol. 59, pp. 100795-100795
Closed Access | Times Cited: 68
Kimberley M. Hanssen, Michelle Haber, Jamie I. Fletcher
Drug Resistance Updates (2021) Vol. 59, pp. 100795-100795
Closed Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 82
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 82
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 762-779
Closed Access | Times Cited: 69
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 762-779
Closed Access | Times Cited: 69
Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy
Xiaogang Zheng, Xiaodong Jin, Fei Ye, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Xiaogang Zheng, Xiaodong Jin, Fei Ye, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer
Ana Podolski-Renić, Ana Čipak Gašparović, Andreia Valente, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116363-116363
Closed Access | Times Cited: 21
Ana Podolski-Renić, Ana Čipak Gašparović, Andreia Valente, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116363-116363
Closed Access | Times Cited: 21
Carbon Dots-Based Nanozyme for Drug-Resistant Lung Cancer Therapy by Encapsulated Doxorubicin/siRNA Cocktail
Hailing Yu, Kexin Tang, Zeyu Cai, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 933-948
Open Access | Times Cited: 23
Hailing Yu, Kexin Tang, Zeyu Cai, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 933-948
Open Access | Times Cited: 23
A hyaluronic acid modified cuprous metal-organic complex for reversing multidrug resistance via redox dyshomeostasis
Yichen Wan, Zelong Chen, Yi Wang, et al.
Carbohydrate Polymers (2023) Vol. 311, pp. 120762-120762
Closed Access | Times Cited: 21
Yichen Wan, Zelong Chen, Yi Wang, et al.
Carbohydrate Polymers (2023) Vol. 311, pp. 120762-120762
Closed Access | Times Cited: 21
Dual-drug codelivery nanosystems: An emerging approach for overcoming cancer multidrug resistance
Jianing Gong, Taoran Shi, Jinfeng Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114505-114505
Open Access | Times Cited: 21
Jianing Gong, Taoran Shi, Jinfeng Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114505-114505
Open Access | Times Cited: 21
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy
Ying Hou, Heng Wang, Jiarui Wu, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1566-1595
Closed Access | Times Cited: 9
Ying Hou, Heng Wang, Jiarui Wu, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1566-1595
Closed Access | Times Cited: 9
The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives
Youming Chen, Zuli Jiang, Ying Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126773-126773
Closed Access | Times Cited: 20
Youming Chen, Zuli Jiang, Ying Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126773-126773
Closed Access | Times Cited: 20
NPs loaded with zoledronic acid as an advanced tool for cancer therapy
Sonia Fathi‐karkan, Mahira Zeeshan, Maimoona Qindeel, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104805-104805
Closed Access | Times Cited: 17
Sonia Fathi‐karkan, Mahira Zeeshan, Maimoona Qindeel, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104805-104805
Closed Access | Times Cited: 17
ABCC1 deficiency potentiated noise-induced hearing loss in mice by impairing cochlear antioxidant capacity
Jing Liu, Yijiang Bai, Yong Feng, et al.
Redox Biology (2024) Vol. 74, pp. 103218-103218
Open Access | Times Cited: 6
Jing Liu, Yijiang Bai, Yong Feng, et al.
Redox Biology (2024) Vol. 74, pp. 103218-103218
Open Access | Times Cited: 6
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6
Unraveling the secrets: Evolution of resistance mediated by membrane proteins
Xue Yang, Min Li, Zi-Chang Jia, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101140-101140
Open Access | Times Cited: 6
Xue Yang, Min Li, Zi-Chang Jia, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101140-101140
Open Access | Times Cited: 6
Rare Earth Luminescent Nanomaterials for Gene Delivery
Jiajun Li, Tao Zhang
(2025), pp. 219-246
Closed Access
Jiajun Li, Tao Zhang
(2025), pp. 219-246
Closed Access
Astragalus-zedoary Inhibits Epithelial–mesenchymal Transition in Colorectal Cancer MC38 Cell Xenograft Mice to Promote Oxaliplatin Attenuation and Sensitization
Lei Liu, Ting Lei, Hua Jiang, et al.
World Journal of Traditional Chinese Medicine (2025)
Open Access
Lei Liu, Ting Lei, Hua Jiang, et al.
World Journal of Traditional Chinese Medicine (2025)
Open Access
Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 811-811
Open Access | Times Cited: 22
Chenmala Karthika, R. Sureshkumar, Mehrukh Zehravi, et al.
Life (2022) Vol. 12, Iss. 6, pp. 811-811
Open Access | Times Cited: 22
Sulforaphane Inhibits Foam Cell Formation and Atherosclerosis via Mechanisms Involving the Modulation of Macrophage Cholesterol Transport and the Related Phenotype
Shiyan Liu, Yuan Zhang, Xiangyu Zheng, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2117-2117
Open Access | Times Cited: 13
Shiyan Liu, Yuan Zhang, Xiangyu Zheng, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2117-2117
Open Access | Times Cited: 13
An orthogonally activatable CRISPR-Cas13d nanoprodrug to reverse chemoresistance for enhanced chemo-photodynamic therapy
Zheng Liu, Zhiyuan Feng, Mohan Chen, et al.
Chemical Science (2023) Vol. 14, Iss. 15, pp. 4102-4113
Open Access | Times Cited: 12
Zheng Liu, Zhiyuan Feng, Mohan Chen, et al.
Chemical Science (2023) Vol. 14, Iss. 15, pp. 4102-4113
Open Access | Times Cited: 12
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 12
Zhi Li, Peihao Yin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188997-188997
Closed Access | Times Cited: 12
Osthole: An up-to-date review of its anticancer potential and mechanisms of action
Shaojie Yang, Wanlin Dai, Jingnan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Shaojie Yang, Wanlin Dai, Jingnan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Modular Biomimetic Strategy Enabled Discovery of Simplified Pseudo-Natural Macrocyclic P-Glycoprotein Inhibitors Capable of Overcoming Multidrug Resistance
Bo Liu, Xueni Yu, Liping Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2550-2565
Closed Access | Times Cited: 11
Bo Liu, Xueni Yu, Liping Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2550-2565
Closed Access | Times Cited: 11
ABCB1 and ABCC1 Function during TGF-β-Induced Epithelial-Mesenchymal Transition: Relationship between Multidrug Resistance and Tumor Progression
Kelli Monteiro da Costa, Leonardo Freire‐de‐Lima, Leonardo Marques da Fonseca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6046-6046
Open Access | Times Cited: 10
Kelli Monteiro da Costa, Leonardo Freire‐de‐Lima, Leonardo Marques da Fonseca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6046-6046
Open Access | Times Cited: 10
Vitamin B12 Metabolism: A Network of Multi-Protein Mediated Processes
Patryk Mucha, Filip Kuś, Dominik Cysewski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8021-8021
Open Access | Times Cited: 3
Patryk Mucha, Filip Kuś, Dominik Cysewski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8021-8021
Open Access | Times Cited: 3
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3